This in turn leads to circulating hyperinsulinemia, which increases liver-derived insulin-like growth factor I (IGF-I) and alters circulating concentrations of IGF-binding proteins (IGF-BPs). The gene discussed is IGF1; the disease is hyperinsulinism.